Michael Chrobok
Impact in
- Immunology top 10%
- Immune Cell Function and Interaction
- Immunotherapy and Immune Responses
- Hematology top 10%
- Multiple Myeloma Research and Treatments
Papers in
-
- Immune Cell Function and Interaction 6
-
- Multiple Myeloma Research and Treatments 3
- Co-authors
- Evren Alici (8 shared papers)Adil Doganay Duru (5 shared papers)Carin I. M. Dahlberg (2 shared papers)Dhifaf Sarhan (1 shared paper)Hareth Nahi (3 shared papers)Arnika Kathleen Wagner (4 shared papers)Johan Lund (2 shared papers)Astrid Gruber (1 shared paper)
- Journals
- Frontiers in Immunology (3 papers)Cancers (2 papers)Frontiers in Cell and Developmental Biology (1 paper)European Journal of Immunology (1 paper)PLoS ONE (1 paper)
- Partner nations
- SwedenUnited StatesTürkiye
In The Last Decade
Michael Chrobok
13 papers receiving 561 citations
Peers
Comparison fields: 5 of 54
- Immunology 229
- Hematology 95
- Oncology 128
- Hepatology 19
- Genetics 16
Countries citing papers authored by Michael Chrobok
This map shows the geographic impact of Michael Chrobok's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Michael Chrobok with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Michael Chrobok more than expected).
Fields of papers citing papers by Michael Chrobok
This network shows the impact of papers produced by Michael Chrobok. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Michael Chrobok. The network helps show where Michael Chrobok may publish in the future.
Co-authors
The 25 scholars most cited alongside Michael Chrobok, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2015 | 154 | |
| 2 | 2019 | 95 | |
| 3 | 2020 | 54 | |
| 4 | 2020 | 51 | |
| 5 | 2022 | 47 | |
| 6 | 2019 | 38 | |
| 7 | 2021 | 30 | |
| 8 | 2019 | 25 | |
| 9 | 2022 | 25 | |
| 10 | 2015 | 20 | |
| 11 | 2023 | 14 | |
| 12 | 2022 | 11 | |
| 13 | 2021 | 9 |
About Michael Chrobok
Michael Chrobok is a scholar working on Immunology, Hematology, Oncology, Hepatology and Reproductive Medicine, having authored 13 papers that have together received 573 indexed citations. Recurring topics across this work include Immune Cell Function and Interaction (6 papers), Multiple Myeloma Research and Treatments (3 papers), CAR-T cell therapy research (2 papers), Pluripotent Stem Cells Research (1 paper), Biomedical Ethics and Regulation (1 paper), Cancer Genomics and Diagnostics (1 paper), Virus-based gene therapy research (1 paper) and Retinal Development and Disorders (1 paper). The work is most often cited by research in Immunology (229 citations), Hematology (95 citations), Oncology (128 citations), Hepatology (19 citations) and Genetics (16 citations). Michael Chrobok has collaborated with scholars based in Sweden, United States and Türkiye. Frequent co-authors include Evren Alici, Adil Doganay Duru, Carin I. M. Dahlberg, Dhifaf Sarhan, Hareth Nahi, Arnika Kathleen Wagner, Johan Lund, Astrid Gruber, Per T Ljungman and Gösta Gahrton. Their work appears in journals such as Frontiers in Immunology, Cancers, Frontiers in Cell and Developmental Biology, European Journal of Immunology and PLoS ONE.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.